CDKN2B‐AS1 upregulation was observed in many cancer types, including HCC [20], and is recognised as a crucial factor in regulating cancer cell proliferation, migration, invasion and metastasis through various mechanisms. This evidence concerns the gene CDKN2B and hepatocellular carcinoma.